Vertex Publishes 2019 Corporate Responsibility Report
May 19, 2020 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX), a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases, announces its 2019 Corporate Responsibility report.
This report shares the company’s corporate responsibility (CR) priorities and progress in 2019. With a focus on 2019 activities, it does not include Vertex and the Vertex Foundation’s global efforts in response to the COVID-19 pandemic. A highlight detailed in the report is the progress Vertex has made in its environmental sustainability efforts. Having reduced global carbon emissions by 39 percent in the past five years, the company has built on these efforts and set a new enterprise goal to reduce absolute global emissions by a further 20 percent by 2023.
“The same values that guide and drive our internal and external innovation—fearlessness, collaboration, and commitment to patients—also fuel our efforts in corporate responsibility.” Reshma Kewalramani, M.D. Chief Executive Officer and President
Media Contact Info: